News
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
PORTLAND, Maine, April 02, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Refinancing of its Bank Debt
PORTLAND, Maine, March 11, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
PORTLAND, Maine, Feb. 19, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
PORTLAND, Maine, Feb. 18, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019
Conference Call Scheduled for Wednesday, February 19, 2020 at 9:00 AM ETPORTLAND, Maine, Feb. 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
PORTLAND, Maine, Jan. 21, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019
PORTLAND, Maine, Nov. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019
Conference Call Scheduled for Monday, November 11, 2019 at 4:30 PM ETPORTLAND, Maine, Nov. 05, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity
PORTLAND, Maine, Sept. 17, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™
PORTLAND, Maine, Sept. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...